pharma
CHEPLAPHARM Arzneimittel
CHEPLAPHARM Arzneimittel GmbH
CHEPLAPHARM Arzneimittel patent portfolio — 10 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Greifswald, DE
- Founded
- 2013
- Programs
- 0
- Drugs
- 0
- Patents
- 10
CHEPLAPHARM Arzneimittel patents
10 pharmaceutical patents indexed for CHEPLAPHARM Arzneimittel. 1 expire within 24 months.
CHEPLAPHARM Arzneimittel has 10 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
AU 2007332640
Powder formulation for valganciclovir
granted -
AU 2001289696
New use of lipase inhibitors
granted -
AU 2001289699
New pharmaceutical composition
expired -
AU 2002212120
Lipase inhibitors for the treatment of dyspepsia
expired -
AU 2001281846
Method for preparing a composition
expired -
AU 2002319189
Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof
expired -
AU 2002257817
Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester
expired -
AU 2003222814
PHARMACEUTICAL COMPOSITION COMPRISING A LIPASE INHIBITOR AND GLUCOMANNAN
expired -
AU 7286300
Dispersion formulations containing lipase inhibitors
expired -
AU 7517700
Solid lipid formulations
expired
Frequently asked questions
How many patents does CHEPLAPHARM Arzneimittel have?
10 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do CHEPLAPHARM Arzneimittel patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.